Seinäjoki adult asthma study (SAAS): A protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Kankaanranta, Hannu ^a,b   Ilmarinen, Pinja ^a   Kankaanranta, Terhi ^c   Tuomisto, Leena E ^a  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Police University College   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; ANTIASTHMATIC AGENT;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ASTHMATIC STATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PATIENT; CHRONIC RHINITIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NOSE OBSTRUCTION; OBESITY; PHENOTYPE; PRIMARY MEDICAL CARE; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; COHORT ANALYSIS; DISEASE COURSE; FINLAND; LONGITUDINAL STUDY; LUNG FUNCTION TEST; ONSET AGE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PULMONOLOGY;

ADULT; AGE OF ONSET; ANTI-ASTHMATIC AGENTS; ASTHMA; COHORT STUDIES; DISEASE PROGRESSION; FINLAND; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; PRIMARY HEALTH CARE; PROGNOSIS; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS;

EID: 84933056028     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2015.42     Document Type: Article

References (35)

1. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention. Revised 2014. Available at www.ginasthma.org.
2. Wenzel SE. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
3. de Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev 2013; 22: 44-52.
4. Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol. 2010; 126: 187-197.
5. Rönmark E, Lindberg A, Watson L, Lundbäck B. Outcome and severity of adult onset asthma-report from the obstructive lung disease in northern Sweden studies (OLIN). Respir Med. 2007; 101: 2370-2377.
6. Westerhof GA, Vollema EM, Weersink EJ, Reinartz SM, de Nijs SB, Bel EH. Predictors for the development of progressive severity in new-onset adult asthma. J Allergy Clin Immunol 2014; 134: 1051-1056.
7. Kankaanranta H, Lahdensuo A, Moilanen E, Barnes PJ. 'Add-on therapy' options in adults with asthma not adequately controlled by inhaled corticosteroids: A comprehensive review. Respir Res 2004; 5: 17.
8. Mercer SW. Comorbidity in asthma is important and requires a generalist approach. Prim Care Respir J 2014; 23: 4-5.
9. Steppuhn H, Langen U, Keil T, Scheidt-Nave C. Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German Health Update (GEDA) 2009 and 2010. Prim Care Respir J 2014; 23: 22-29.
10. Haahtela T, Lehtimäki L, Ahonen E, Harju T, Jartti T, Kankaanranta H et al. Update on current guidelines: Asthma. Duodecim 2013; 129: 994-995.
11. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014. Available at www.goldcopd. org.
12. Kankaanranta H, Harju T, Kilpeläinen M, Mazur W, Lehto JT, Katajisto M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: The Finnish guidelines. Basic Clin Pharmacol Toxicol 2015; 116: 291-307.
13. Tuomisto L. Asthma programme in Finland-management of adult asthma as reflected by referral letters (Acta Universitatis Tamperensis). Tampere University Press: Tampere, Finland: Tampere, Finland, 2010. Available at http:// tampub.uta.fi/handle/10024/59337/browse?value = Tuomisto%2C+Leena&type = author.
14. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA. Asthma Programme in Finland: A community problem needs community solutions. Thorax 2001; 56: 806-814.
15. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
16. Tuomisto LE, Erhola M, Luukkaala T, Puolijoki H, Nieminen MM, Kaila M. Asthma Programme in Finland: did the use of secondary care resources become more rational. Respir Med 2010; 104: 957-965.
17. Blakey JD, Woolnough K, Fellows J, Walker S, Thomas M, Pavord ID. Assessing the risk of attack in the management of asthma: A review and proposal for revision of the current control-centered paradigm. Prim Care Respir J 2013; 22: 344-352.
18. Ilmarinen P, Kankaanranta H. Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol 2014; 114: 109-117.
19. Leivo-Korpela S, Lehtimäki L, Vuolteenaho K, Nieminen R, Kööbi L, Järvenpää R et al. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD. Respir Med 2014; 108: 122-128.
20. Ilmarinen P, Moilanen E, Erjefält J, Kankaanranta H. The polyamine spermine promotes survival and activation of human eosinophils. J Allergy Clin Immunol 2015; e-pub ahead of print 30 January 2015; doi:10.1016/j.jaci.2014.12.1922.
21. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergol Int 2014; 63: 143-151.
22. Kankaanranta T, Nummi T, Vainiomäki J, Halila H, Hyppölä H, Isokoski M et al. The role of job satisfaction, job dissatisfaction and demographic factors on physician's interventions to switch work sector from public to private. Health Policy 2007; 83: 50-65.
23. Kankaanranta T, Rissanen P. The labour supply of registered nurses in Finland: The effect of wages and working conditions. Eur J Health Econ 2009; 10: 167-178.
24. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
25. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X et al. National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181: 315-323.
26. Siroux V, Basagaña X, Boudier A, Pin I, Garcia-Aymerich J, Vesin A et al. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011; 38: 310-317.
27. Tuomisto LE, Ilmarinen P, Kankaanranta H. Prognosis of new-onset asthma diagnosed at adult age. Respir Med 2015; e-pub ahead of print 21 May 2015; doi:10.1016/j.rmed.2015.05.001.
28. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41: 716-726.
29. Spears M, McSharry C, Chaudhuri R, Weir CJ, de Wet C, Thomson NC. Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study. PLoS One 2013; 8: e71460.
30. Herland K, Akselsen J-P, Skjønsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger 'real life' population of patients with obstructive lung disease. Respir Med 2005; 99: 11-19.
31. Kauppi P, Linna M, Martikainen J, Mäkelä MJ, Haahtela T. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax 2013; 68: 292-293.
32. Tuomisto LE, Erhola M, Kaila M, Brander P, Kauppinen R, Puolijoki H et al. The Finnish national asthma programme: communication in asthma care-quality assessment of asthma referral letters. J Eval Clin Pract 2007; 13: 50-54.
33. Tuomisto LE, Kaila M, Erhola M. Asthma programme in Finland: comparison of adult asthma referral letters in 1994 and 2001. Respir Med 2007; 101: 595-600.
34. Tuomisto LE, Järvinen V, Laitinen J, Erhola M, Kaila M, Brander P. Asthma Programme in Finland: The quality of primary care spirometry is good. Prim Care Respir J 2008; 17: 226-231.
35. Martinez-Gonzalez NA, Tandjung R, Djalali S, Huber-Geismann F, Markun S, Rosemann T. Effects of physician-nurse substitution on clinical parameters: A systematic review and meta-analysis. PLoS One 2014; 9: e89181.